Explore evidence

11.8 %The prevalence of overweight/obesity was 11.8% in boys in nursery and primary school children in urban Cameroon.

Camerounoverweight/obesitypublished 2017BMC obesityeurope_pmcdocument of 5 observationsDOI 10.1186/s40608-017-0146-4

75 %In 2013, three-quarters of diabetes-attributable deaths in the Africa Region (AFR) occurred in people under 60 years old.

Cameroundiabète (non précisé)observed 2013published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations

65.6 %The age-standardized treatment rate for diabetes alone was 65.6% among men in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé)observed 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696

25 %A high rate of hospital discharge upon request was recorded among patients with foot problems (25% of the cases).

Camerounpied diabétiqueobserved November 1999 to October 2000published 2006The international journal of lower extremity woundseurope_pmcdocument of 6 observations

52 %Fifty-two percent of the recruited HIV-infected Cameroonians were using a stavudine-containing regimen.

CamerounVIH/sidapublished 2013Diabetes & metabolismeurope_pmcdocument of 12 observations

398 pmol/lBasal C-peptide was not different between participants with type 2 diabetes and ketosis-prone diabetes, with median values of 398 pmol/l vs. 330 pmol/l.

Cameroundiabète de type 2 · ketosis-prone diabetespublished 2022Frontiers in public healtheurope_pmcdocument of 6 observationsDOI 10.3389/fpubh.2022.866107

90 %In 2010, 90% of 40 ART sites in Cameroon attained the target for good ARV prescribing practices (target = 100%).

CamerounVIH/sidaobserved 2010published 2012PLoS ONEOpenAlexdocument of 5 observationsDOI 10.1371/journal.pone.0036777

5.5 mmol/lMean capillary glycemia was 5.5 mmol/l prehemodialysis and 5.3 mmol/l posthemodialysis in type 2 diabetic patients with end-stage renal disease on maintenance hemodialysis.

Cameroundiabète de type 2 · end-stage renal diseasepublished 2010Diabetes careeurope_pmcdocument of 5 observationsDOI 10.2337/dc09-2176

26.4 %Among patients with type 1 diabetes (T1D), 26.4% cited lack of support as a reason for insulin discontinuation.

Cameroundiabète de type 1observed 2016-2017published 2021Advances in therapyeurope_pmcdocument of 12 observations

3.3 log10_copies_per_mlPlasma viral load declined by a median of 3.3 log10 copies/ml at 12 months.

CamerounVIH/sidaobserved 12 monthspublished 2005Antiviral TherapyOpenAlexdocument of 8 observationsDOI 10.1177/135965350501000208

13 /20Patient education through WhatsApp improved knowledge on diabetes in the intervention group from 13/20 to 16/20.

Cameroundiabète de type 1published 2019Pediatric diabeteseurope_pmcdocument of 5 observations

9.2 %At endpoint, 9.2% of 141 HIV-infected adult patients died.

CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680

58 décèsEn 2015, 58 décès liés au paludisme ont été enregistrés à Bafia.

Camerounpaludismeobserved 2015HAL · Unilimdocument of 67 observations

12.1 %Diabetes prevalence in 2021 was estimated to be higher in urban areas (12.1%) than in rural areas (8.3%).

Cameroundiabète (non précisé)observed 2021published 2022Diabetes research and clinical practiceeurope_pmcdocument of 7 observationsDOI 10.1016/j.diabres.2021.109119

7,514 casesThe genome-wide association study of type 1 diabetes included 7,514 cases.

Cameroundiabète de type 1published 2009Nature geneticseurope_pmcdocument of 5 observationsDOI 10.1038/ng.381

-0.32 SMDHIV infection was associated with lower body mass index with a standardized mean difference of -0.32.

Camerounbody mass index · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

19.3 %Secondary foot complication was the associated cause of mortality in 19.3% of cases of death (6 out of 31) in this study.

Camerounpied diabétiqueobserved November 1999 to October 2000published 2006The international journal of lower extremity woundseurope_pmcdocument of 6 observations

14.2 %Pretreatment HIV drug resistance (PDR) prevalence among ART initiators in urban areas of Cameroon was 14.2% (95% CI 6.6%–27.9%).

CamerounVIH/sidaobserved 2015published 2018The Journal of antimicrobial chemotherapyeurope_pmcdocument of 12 observationsDOI 10.1093/jac/dky221

18.3 %According to the National Malaria Control Programme (NMCP) report, 18.3% of hospital deaths were due to malaria in 2019.

Camerounpaludismeobserved 2019HAL · Unilimdocument of 106 observations

90 patientsNinety patients reported 101 suspected adverse drug reactions (ADRs) in a study of 350 patients with type 2 diabetes mellitus in Yaoundé, Cameroon.

Cameroundiabète de type 2published 2020European journal of clinical pharmacologyeurope_pmcdocument of 6 observations

19 %The prevalence of sickle cell trait was 19% in a Cameroonian population of 73 outpatients with Type 2 diabetes at the Yaounde National Diabetes and Obesity Centre.

Cameroundiabète de type 2 · trait drépanocytairepublished 2012Diabetic medicine : a journal of the British Diabetic Associationeurope_pmcdocument of 2 observations

112 mmHgThe mean nighttime systolic blood pressure was 112 ± 11 mmHg in the diabetic group.

Cameroundiabète de type 1published 2017World journal of diabeteseurope_pmcdocument of 9 observations

16.6 %Serologic reactivity suggesting Simian immunodeficiency virus infection was found in 131 of 788 monkey sera, representing 16.6%.

CamerounSimian immunodeficiency viruspublished 2002Emerging infectious diseasesOpenAlexdocument of 3 observationsDOI 10.3201/eid0805.010522

50 %Over half of HIV+ persons attending a health campaign had undetectable HIV RNA one year after implementing intensified community-based HIV testing and linkage.

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

4.4 %Diabetes prevalence in low-income countries in the Africa Region (AFR) was 4.4%.

Cameroundiabète (non précisé)published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations